Kyrieckos Aleck is a Rare/Genetic physician. OpenAlex indexes 26 publications with 1,085 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2211 Lomas Blvd NE
Albuquerque, NM 871062719
Telephone
505-272-4107Provider last certified this registry record 1 Dec 2024.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year202530 payments$42,606openpaymentsdata.cms.gov ↗
- Takeda Pharmaceuticals U.S.A., Inc.Program year20251 payment
- GENZYME CORPORATIONProgram year202482 payments$113,960openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Glucosylceramide Synthase Inhibitor100%Cerdelga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Alternative genomic diagnoses for individuals with a clinical diagnosis of Dubowitz syndrome
American Journal of Medical Genetics Part A
2020 - Intravenous 2-hydroxypropyl-beta-cyclodextrin for a Niemann-Pick disease type C1 infant with liver cirrhosis
Molecular Genetics and Metabolism
2019 - Superior vena cava syndrome in an infantile onset Pompe patient
Molecular Genetics and Metabolism
2019 - Premedication and dose regimen for a type 1 Gaucher patient with severe ERT intolerance
Molecular Genetics and Metabolism
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Ronald Wapner, MD
Columbia University Irving Medical Center
William Dobyns, MD
Robert Desnick, PhD, MD
Mount Sinai Health System
Stephen Gruber, MD
City Of Hope National Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”